Morphotek

BiotechnologySeries DExton, USmorphotek.com

Latest round

Series D

Last raised

Oct 2006

Total raised

$76M

Investors

13

About Morphotek

Morphotek, Inc. is a biopharmaceutical company. It engages in the discovery and development of therapeutic monoclonal antibodies for the treatment of cancer, inflammatory, and infectious diseases.

Who invested in Morphotek

13 investors across 3 rounds

See all investors in Morphotek

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series D

    Oct 12, 2006

    Amount

    $40M

    Investors

    Locked

  2. Series C

    Feb 18, 2004

    Amount

    $26M

    Investors

    Locked

  3. Series B

    Aug 1, 2001

    Amount

    $10M

    Investors

    Locked

Questions about Morphotek

Who invested in Morphotek?

Morphotek has 13 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Morphotek raised?

Morphotek has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did Morphotek last raise money?

Morphotek's most recent round on record is a Series D, in Oct 2006.

What does Morphotek do?

Morphotek is a biotechnology company.

Where is Morphotek headquartered?

Morphotek is headquartered in Exton, US.

Which VCs invest in companies like Morphotek?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Morphotek's stage. Their profiles are linked below.

Raising like Morphotek? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.